Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis? — Jae Il Shin (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis?
JS
Shared by
Jae Il Shin
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis?
Letter
2011
en
Authors
JS
Jae Il Shin
SP
Se Jin Park
JK
Ji Hong Kim
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2011
Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe
Jae Il Shin
,
Se Jin Park
,
Ji Hong Kim
Letter
2012
What should be the indications for fibrinolytic therapy in children with severe Henoch–Schönlein purpura nephritis?
Se Jin Park
,
Jae Il Shin
Letter
2008
Intravenous Cyclophosphamide Therapy in Adults with Henoch-Schönlein Purpura
Jae Il Shin
,
Jae Seung Lee
Article
2005
Serum IgA/C3 Ratio May Be a Useful Marker of Disease Activity in Severe Henoch-Schönlein Nephritis
Jae Il Shin
,
Jee Min Park
,
Youn Ho Shin
,
Jae Seung Lee
,
Hyeon Joo Jeong
,
Hyun Sook Kim
Letter
2005
Development of Graves' disease during cyclosporin treatment for severe Henoch–Schönlein nephritis
Jae Il Shin
,
Jee Min Park
,
Jae Seung Lee
,
Duk Hee Kim
,
Hyeon Joo Jeong
Discussion(0)
No comments yet. Be the first to comment.